Recent advances in miRNA delivery systems

I Dasgupta, A Chatterjee - Methods and protocols, 2021 - mdpi.com
MicroRNAs (miRNAs) represent a family of short non-coding regulatory RNA molecules that
are produced in a tissue and time-specific manner to orchestrate gene expression post …

[HTML][HTML] Kojic acid applications in cosmetic and pharmaceutical preparations

M Saeedi, M Eslamifar, K Khezri - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Skin color disorders can be caused by various factors, such as excessive exposure to
sunlight, aging and hormonal imbalance during pregnancy, or taking some medications …

Combinational strategy for high-performance cancer chemotherapy

SY Qin, YJ Cheng, Q Lei, AQ Zhang, XZ Zhang - Biomaterials, 2018 - Elsevier
The clinical outcomes of conventional mono-chemotherapy of cancers are usually far from
satisfactory due to some issues such as tumor heterogeneity and resistance to …

Threatening cancer with nanoparticle aided combination oncotherapy

S Rawal, MM Patel - Journal of controlled release, 2019 - Elsevier
Employing combination therapy has become obligatory in cancer cases exhibiting high
tumor load, chemoresistant tumor population, and advanced disease stages. Realization of …

Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer

X Lai, M Eberhardt, U Schmitz, J Vera - Nucleic acids research, 2019 - academic.oup.com
MicroRNAs (miRNAs) are short, noncoding RNAs that regulate gene expression by
suppressing mRNA translation and reducing mRNA stability. A miRNA can potentially bind …

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy

S Liu, AR Khan, X Yang, B Dong, J Ji, G Zhai - Journal of Controlled …, 2021 - Elsevier
Multidrug resistance (MDR) of cancer is a persistent problem in chemotherapy. Scientists
have considered the overexpressed efflux transporters responsible for MDR and …

Understanding and targeting resistance mechanisms in cancer

ZN Lei, Q Tian, QX Teng, JND Wurpel, L Zeng… - MedComm, 2023 - Wiley Online Library
Resistance to cancer therapies has been a commonly observed phenomenon in clinical
practice, which is one of the major causes of treatment failure and poor patient survival. The …

Progress in natural compounds/siRNA co-delivery employing nanovehicles for cancer therapy

M Ashrafizadeh, A Zarrabi, K Hushmandi… - ACS combinatorial …, 2020 - ACS Publications
Chemotherapy using natural compounds, such as resveratrol, curcumin, paclitaxel,
docetaxel, etoposide, doxorubicin, and camptothecin, is of importance in cancer therapy …

Nanotechnology approaches in the current therapy of skin cancer

LN Borgheti-Cardoso, JSR Viegas… - Advanced Drug Delivery …, 2020 - Elsevier
Skin cancer is a high burden disease with a high impact on global health. Conventional
therapies have several drawbacks; thus, the development of effective therapies is required …

A review on liposome-based therapeutic approaches against malignant melanoma

F Mirzavi, M Barati, A Soleimani… - International journal of …, 2021 - Elsevier
Melanoma is a highly aggressive form of skin cancer with a very poor prognosis and
excessive resistance to current conventional treatments. Recently, the application of the …